Upstream Bio, Inc. (UPB)

5.375 +0.20 (+3.97%) USD  |  NASDAQ  |  Sep 25, 16:00
5.375 0.00 (0.00%) After-Hours: 16:28
More

Upstream Bio Cash and Short Term Investments (Quarterly) : 261.31M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for UPB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 261.31M
March 31, 2026 294.58M
December 31, 2025 341.51M
September 30, 2025 372.43M
Date Value
June 30, 2025 393.58M
March 31, 2025 431.38M
December 31, 2024 470.45M
September 30, 2024 220.66M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Sutro Biopharma, Inc. 164.35M
Compass Therapeutics, Inc. 179.88M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M